Skip to content
Late-StageResearch compound

Clenbuterol

Airway-widening asthma drug that bodybuilders use off-label for fat loss; can harm the heart and is banned in competitive sport.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Clenbuterol vial

Related comparisons

Clenbuterol vs Albuterol

DETAILED OVERVIEW

What is Clenbuterol?

Clenbuterol is an airway-widening drug originally developed for asthma. In Hungary it is approved as a veterinary medicine for horses with asthma; in a few countries it is also a human asthma medicine, but in the United States it is not approved for human use. Bodybuilders use it off-label to burn fat and to avoid losing muscle while dieting.

Like adrenaline, it stimulates the body: it relaxes the muscles of the airways and boosts fat breakdown and heat production. In one human study it increased lean body mass but reduced endurance. It leaves the body very slowly, so an overdose can cause a racing heart, chest pain and low potassium. With long-term use, animal studies found a thickened, scarred heart muscle, and cases of human heart muscle disease are known. It must not be used in pregnancy, and it is banned in competitive sport, both in and out of competition.

Mechanism

Selective β2-adrenoceptor agonist

Half-life

35-40 hours

Onset

15-30 min

Legal status

EU: vet-Rx (equine asthma). HU: vet-Rx. USA: not approved for humans.

Data console

Lab data

Androgenic:Anabolic-
AR bindingN/A
Active half-life35-40 h
Detection window7-14 days urine (sensitive LC-MS testing in WADA-accredited labs).
AromatizationNot applicable – β2-agonist bronchodilator, NOT a steroid; no aromatase substrate
HepatotoxicityLow – cardiotoxicity dominates (cardiomyocyte damage, hypertrophy, arrhythmia); negligible hepatic load (Beermann 2009)

Safety

Side effects, stop signs, contraindications

Side effects · 8

  • Tachycardia and palpitations: β2 (and partial β1) stimulation raises resting heart rate by 20-30 bpm; sustained tachycardia stresses the myocardium.
  • Muscle tremor, especially of the hands: a classic dose-dependent effect of peripheral β2-receptors, appearing even at a 20 μg starting dose.
  • Muscle cramps and hypokalemia: β2 stimulation shifts potassium intracellularly; low serum potassium causes cramps and, rarely, rhabdomyolysis (taurine and magnesium ease it).
  • Insomnia, anxiety and restlessness: the 35-40 hour half-life prolongs the stimulant effect, and evening dosing worsens sleep.
  • Left ventricular hypertrophy (LVH): chronic use over 8 weeks causes documented LVH, fibrosis and arrhythmia in animal studies, with human cardiomyopathy cases reported.
  • Excessive sweating, hot flushes and raised blood pressure: from the thermogenic β2 effect and sympathetic activation, worsened by dehydration.
  • Headache and nausea: common sympathomimetic side effects, mainly during the upward phase of dose titration.
  • Risk of acute overdose due to the long half-life: tachyarrhythmia, chest pain, vomiting and hypokalemia with toxicity symptoms (poisons-centre cases documented).

Contraindications · 7

  • Any cardiovascular disease: hypertension, arrhythmia, ischaemic heart disease, prior heart attack or a positive family history are absolute contraindications.
  • Cardiomyopathy and left ventricular hypertrophy: clenbuterol further worsens myocardial hypertrophy and fibrosis, raising the risk of sudden cardiac death.
  • Hyperthyroidism: an overactive thyroid combined with β2 stimulation causes extreme sympathetic overactivation and cardiotoxic load.
  • Beta-blocker therapy: beta-blockers pharmacologically conflict with clenbuterol, and the combination can cause unpredictable cardiovascular reactions.
  • Pregnancy and breastfeeding: teratogenic and cardio-developmental effects in animal studies, and contraindicated due to its uterine-relaxant effect.
  • Epilepsy or a history of seizures: β2 stimulation and the accompanying hypokalemia lower the seizure threshold.
  • Severe anxiety disorder or panic disorder: the stimulant, sympathomimetic profile worsens anxiety, palpitations and insomnia.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Clenbuterol?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.